Shibata S, Watanabe A, Hamada T, Watanabe S
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University 62, Fukuoka, Japan.
Neurosci Lett. 1994 Feb 28;168(1-2):159-62. doi: 10.1016/0304-3940(94)90440-5.
The mammalian suprachiasmatic nucleus (SCN) has been identified as a circadian pacemaker. N-methyl-D-aspartate (NMDA), non-NMDA and substance P receptors have been suggested to be involved in handling of photic information in the SCN. In the Aplysia eyes, in which the circadian clocks are involved, serotonin- or cAMP-induced phase changes of the circadian rhythm were reported to be blocked by protein-synthesis inhibitors. Therefore, we investigated whether protein-synthesis inhibitor can block the non- NMDA receptor agonist (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrobromide (AMPA)- or substance P (SP)-induced phase changes of SCN activity rhythm. Although application of 10 microM cycloheximide alone during the early part of the subjective night did not cause phase change, it blocked both 10 microM AMPA- and 1 microM SP-induced phase delay. The present result suggests that protein synthesis may be required in the manifestation of AMPA- and SP-induced phase change of circadian clock.
哺乳动物的视交叉上核(SCN)已被确定为昼夜节律起搏器。N-甲基-D-天冬氨酸(NMDA)、非NMDA和P物质受体被认为参与了SCN中光信息的处理。在涉及昼夜节律时钟的海兔眼睛中,据报道,蛋白质合成抑制剂可阻断5-羟色胺或环磷酸腺苷诱导的昼夜节律相位变化。因此,我们研究了蛋白质合成抑制剂是否能阻断非NMDA受体激动剂(R,S)-α-氨基-3-羟基-5-甲基异恶唑-4-丙酸氢溴酸盐(AMPA)或P物质(SP)诱导的SCN活动节律的相位变化。尽管在主观夜间早期单独应用10微摩尔的放线菌酮不会引起相位变化,但它阻断了10微摩尔AMPA和1微摩尔SP诱导的相位延迟。目前的结果表明,在AMPA和SP诱导的昼夜节律时钟相位变化的表现中可能需要蛋白质合成。